We have previously found raised serum IgG antibody levels to native type II collagen in 49% of patients with rheumatoid arthritis (RA) 46% There was a very good correlation between the serum IgG and IgM antibody levels in patients with RA, though in 5 patients only the serum IgM antibody levels were raised. The correlation between the serum IgG and IgM antibody levels in JCA was far weaker, though significant. This was due to the fact that this group is composed of all the different arthritides. The highest serum IgG and IgM antibody levels to native type II collagen were found in RA. There was a lack of correlation between serum IgG and IgM antibody levels to native type II collagen in the patients with ankylosing spondylitis and psoriatic arthritis.
Native type IL collagen is found mainly in articular cartilage but also in the eye'5 and the intervertebral disc. 16 As ocular involvement is a feature in many of the arthritides, the development of immunity to native type II collagen could play a role in the pathogenesis of the eye lesions. However, none of the 3 patients with ankylosing spondylitis and a previous history of acute iridocyclitis (uveitis) had a raised serum IgG or IgM antibody level to native type II collagen, and only 1 of the 3 patients with juvenile chronic arthritis and long-standing chronic iridocyclitis had raised serum IgG and IgM antibody levels to native type II collagen. Although only 1 patient had his serum tested within 1 month of the onset of the eye lesion, the fact that all the patients with very high serum IgG and IgM antibody levels to native type II collagen had no overt eye disease suggests that humoral immunity to native type II collagen does not play a role in the pathogenesis of the ocular lesions associated with the arthritides.
The patients with rheumatoid arthritis appear capable of producing high serum levels of both IgG and IgM antibodies to native type II collagen. Patients suffering from the other forms of chronic inflammatory arthritides are capable of producing only moderately raised serum antibody levels, which are almost exclusively IgG antibody to native type II collagen. These findings are in keeping with the results on serum antiglobulin levels, which are highest in patients with RA and in these patients are composed of both IgG and IgM antibodies.2 Low levels of raised serum IgG antiglobulin may be found in patients suffering from the 'seronegative' chronic inflammatory arthritides.2 [17] [18] [19] The reasons for the highest levels of serum antibodies to native type II collagen occurring in RA are unknown. Rheumatoid patients with high titres of antiglobulins (< 1/1280) and nodules, frequently possess the major histocompatibility antigen HLA DWR3, though RA is associated with HLA DWR4.20 In inbred mice the level of humoral immune response to native type Il collagen has been linked with the major histocompatibility complex H2.21 Thus a possible association between high serum antibody levels to native type II collagen and the HLA system requires investigation. However, patients with RA usually suffer more severe joint destruction than the majority of patients with seronegative arthritis, so that the greater release of native type IL collagen from articular cartilage could lead to greater stimulation of the immune response. Further studies on these factors are in progress.
Normally IgM antibody production is short-lived after an antigenic stimulus and falls back to normal within 6 weeks. In contrast IgG antibody production can persist at high levels for prolonged periods, especially after antigenic boosting. In rheumatoid arthritis, however, there appears to be an immunological abnormality in that IgM, as well as IgG, antibody production may persist at high levels. The cause of this persistent production of IgM antibody is unknown, though one reason may be the persistence of antigenic stimulation. This immunological abnormality may have important pathogenetic significance, in both the intra-and extra-articular manifestations of RA, as IgM antibody binds complement more efficiently than IgG. This increased complement activation by IgM antibody could then lead to a more severe inflammatory response and result in the more severe articular and extra-articular lesions associated with RA. The pathogenetic significance of IgG and IgM antibodies to native type IL collagen is now being investigated. 
